April 1 | 8 p.m. ET
RACE-Approved CE Credit Hours: 1
Free to attend
This webinar explores ertugliflozin as a treatment for equine hyperinsulinemia, using real-world case examples and emerging evidence. It will address patient selection, treatment and monitoring strategies, and practical considerations for applying research to everyday clinical care in horses at risk of metabolic disease and laminitis.